French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...

Just a few weeks France's Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – but it is Novartis that has swooped on the company and ...

The Tavascan is Cupra’s second fully electric vehicle, but also its first electric SUV. Rather than this leading to a dumbing down of the brand’s sporty styling, the car’s performance-led ...